Train-of-four and tetanic fade are not always a prejunctional phenomenon as evaluated by toxins having highly specific pre-and postjunctional actions

Anesthesia and Analgesia

Volumn 116, Issue 5, 2013, Pages 994-1000

  Nagashima, Michio ^a,b   Yasuhara, Shingo ^a,b   Martyn, J A Jeevendra ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; BOTULINUM TOXIN A; DIHYDRO BETA ERYTHROIDINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA1; NICOTINIC RECEPTOR ALPHA3BETA2; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; FUNCTION TEST; IN VIVO STUDY; MALE; MUSCLE DENERVATION; MUSCLE EXCITATION; MUSCLE MASS; MUSCLE TETANIC CONTRACTION; NERVOUS SYSTEM PARAMETERS; NEUROMUSCULAR FUNCTION; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCIATIC NERVE; TETANIC FADE; TIBIALIS ANTERIOR MUSCLE; TRAIN OF FOUR FADE; WESTERN BLOTTING;

ACETYLCHOLINE; ANESTHESIA; ANIMALS; BOTULINUM TOXINS; BUNGAROTOXINS; DIHYDRO-BETA-ERYTHROIDINE; ELECTRIC STIMULATION; MALE; MONITORING, INTRAOPERATIVE; MUSCLE CONTRACTION; NEUROMUSCULAR JUNCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLINERGIC; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SYNAPTIC TRANSMISSION; TOXINS, BIOLOGICAL;

EID: 84876763079     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31828841e3     Document Type: Article

References (27)

1. Brull SJ, Murphy GS. Residual neuromuscular block: Lessons unlearned. Part II: Methods to reduce the risk of residual weakness. Anesth Analg 2010;111:129-40
2. Murray MJ, Cowen J, DeBlock H, Erstad B, Gray AW Jr, Tescher AN, McGee WT, Prielipp RC, Susla G, Jacobi J, Nasraway SA Jr, Lumb PD; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002;30:142-56
3. Brull SJ, Naguib M. What we know: Precise measurement leads to patient comfort and safety. Anesthesiology 2011;115:918-20
4. Bowman WC. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth Analg 1980;59:935-43
5. Naguib M, Lien C. Pharmacology of muscle relaxants and their antagonist. In: Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, eds. Miller's Anesthesia. 7th ed. Philadelphia, PA: Churchill Livingstone, 2010:859-911
6. Fagerlund MJ, Eriksson LI. Current concepts in neuromuscular transmission. Br J Anaesth 2009;103:108-14
7. Vizi ES, Lendvai B. Side effects of nondepolarizing muscle relaxants: Relationship to their antinicotinic and antimuscarinic actions. Pharmacol Ther 1997;73:75-89
8. Bowman WC, Marshall IG, Gibb AJ, Harborne AJ. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol Sci 1988;9:16-20
9. Bowman WC, Prior C, Marshall IG. Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci 1990;604:69-81
10. Faria M, Oliveira L, Timóteo MA, Lobo MG, Correia-De-Sá P. Blockade of neuronal facilitatory nicotinic receptors containing alpha 3 beta 2 subunits contribute to tetanic fade in the rat isolated diaphragm. Synapse 2003;49:77-88
11. Lu Z, Yu B. Role of presynaptic acetylcholine autoreceptors at motor nerve endings on tetanic and train-of-four fade seen during a nondepolarizing neuromuscular block. Anesthesiology 2007;106:1243; author reply 1243-4
12. Jonsson M, Gurley D, Dabrowski M, Larsson O, Johnson EC, Eriksson LI. Distinct pharmacologic properties of neuromuscular blocking agents on human neuronal nicotinic acetylcholine receptors: A possible explanation for the train-of-four fade. Anesthesiology 2006;105:521-33
13. Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes. J Pharmacol Exp Ther 1997;280:346-56
14. Frick CG, Richtsfeld M, Sahani ND, Kaneki M, Blobner M, Martyn JA. Long-Term effects of botulinum toxin on neuromuscular function. Anesthesiology 2007;106:1139-46
15. Frick CG, Fink H, Blobner M, Martyn J. A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites. Anesth Analg 2012;114:102-9
16. Ma J, Shen J, Lee CA, Elsaidi GA, Smith TL, Walker FO, Rushing JT, Tan KH, Koman LA, Smith BP. Gene expression of nAChR, SNAP-25 and GAP-43 in skeletal muscles following botulinum toxin A injection: A study in rats. J Orthop Res 2005;23:302-9
17. Correia-de-Sa P, Ribeiro JA: Tonic adenosine A2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur J Pharmacol 1994; 271: 349-55
18. Witzemann V, Brenner HR, Sakmann B. Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses. J Cell Biol 1991;114:125-41
19. Apel C, Rícný J, Wagner G, Wessler I. alpha-Bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin and erabutoxin-b do not affect [3H]acetylcholine release from the rat isolated left hemidiaphragm. Naunyn Schmiedebergs Arch Pharmacol 1995;352:646-52
20. Lindstrom JM. Nicotinic acetylcholine receptors of muscles and nerves: Comparison of their structures, functional roles, and vulnerability to pathology. Ann N Y Acad Sci 2003;998:41-52
21. Boulter J, Connolly J, Deneris E, Goldman D, Heinemann S, Patrick J. Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc Natl Acad Sci USA 1987;84:7763-7
22. Nitahara K, Sugi Y, Higa K, Shono S, Hamada T. Neuromuscular effects of sevoflurane in myasthenia gravis patients. Br J Anaesth 2007;98:337-41
23. Suzuki T, Nagai H, Katsumata N, Ogawa S, Suzuki H. Investigation of fading responses induced by non-depolarising muscle relaxants in the evoked EMG of the gastrocnemius muscle of the cat. Acta Anaesthesiol Scand 1999;43:658-62
24. Chang CC, Hong SJ. Dissociation of the end-plate potential run-down and the tetanic fade from the postsynaptic inhibition of acetylcholine receptor by alpha-neurotoxins. Exp Neurol 1987;98:509-17
25. De Lorenzo S, Veggetti M, Muchnik S, Losavio A. Presynaptic inhibition of spontaneous acetylcholine release mediated by P2Y receptors at the mouse neuromuscular junction. Neuroscience 2006;142:71-85
26. Santafé MM, Salon I, Garcia N, Lanuza MA, Uchitel OD, Tomàs J. Modulation of ACh release by presynaptic muscarinic autoreceptors in the neuromuscular junction of the newborn and adult rat. Eur J Neurosci 2003;17:119-27
27. Wessler I. Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors. Trends Pharmacol Sci 1989;10:110-4